Skip to main content
Erschienen in: Clinical Rheumatology 8/2016

29.06.2016 | Original Article

Nailfold capillaroscopy assessment of microcirculation abnormalities and endothelial dysfunction in children with primary or secondary Raynaud syndrome

verfasst von: Joanna Latuskiewicz-Potemska, Antonina Chmura-Skirlinska, Ryszard J. Gurbiel, Elzbieta Smolewska

Erschienen in: Clinical Rheumatology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Raynaud syndrome (RS) manifests as episodes of transient spasms of peripheral blood vessels, most often in response to cold. The reason of that symptom (primary RS (pRS)) usually cannot be found but may be accompanied by some autoimmune diseases (secondary RS (sRS)). In this study, we assessed microcapillary status and serum concentrations of chosen cytokines, adhesive molecules, and nitric oxide (NO) in patients with pRS and sRS in comparison with healthy children. Eighty-six patients with RS were enrolled into the study, including 52 with pRS and 34 with sRS. The control group consisted of 29 healthy children. A decrease in myorelaxative and anticoagulant abilities was observed, with simultaneous prevalence of vasopressor substances and procoagulative activity. Therefore, several important factors such as endothelin-1 (ET-1), E-selectin (E-sel), interleukin-18 (IL-18), and nitrogen oxide (NO) were also analyzed. Two types of capillaroscopy status were determined: normal and microangiopathic. There was a significant relationship between presence of microangiopathy and higher serum ET-1 (p = 0.018) and E-sel (p = 0.021) levels. Similarly, we have found a correlation between presence of ANA and higher ET-1 (p = 0.005), but not E-sel (p = 0.241). In patients with pRS, we found significant relationship between ANA and higher ET-1 (p = 0.008). No such relations were observed in sRS patients. Our data indicates that external factor-induced vasoconstrictive effects dominated in pRS, whereas in sRS in the course of connective tissue diseases, it was accompanied by coexistent vasodilation due to endothelial dysfunction. The latter phenomenon is at least partially dependent on insufficient NO release.
Literatur
1.
Zurück zum Zitat Gryglewska B (2010) The role of microcirculation in hypertension and its assessment based on skin microvasculature function testing (in Polish). Arterial Hypertens 5:395–410 Gryglewska B (2010) The role of microcirculation in hypertension and its assessment based on skin microvasculature function testing (in Polish). Arterial Hypertens 5:395–410
2.
4.
Zurück zum Zitat Bakst R, Merola JF, Franks AG Jr, Sanchez M et al (2008) Raynaud’s phenomenon: pathogenesis and management. J Am Acad Dermatol 59:633–653CrossRefPubMed Bakst R, Merola JF, Franks AG Jr, Sanchez M et al (2008) Raynaud’s phenomenon: pathogenesis and management. J Am Acad Dermatol 59:633–653CrossRefPubMed
5.
Zurück zum Zitat Barton M (2005) Endothelin in the microvasculature in basic science part 1, Chapter 1. Elsevier Science, USA, pp 5–12 Barton M (2005) Endothelin in the microvasculature in basic science part 1, Chapter 1. Elsevier Science, USA, pp 5–12
6.
Zurück zum Zitat Bӧhm F, Pernow J (2007) The importance of endotelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76:8–18CrossRef Bӧhm F, Pernow J (2007) The importance of endotelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res 76:8–18CrossRef
7.
Zurück zum Zitat Rajagopalan S, Pfenninger D, Kehrer C et al (2003) Increased asymmmetric dimethylarginine and endothelin1 levels in secondary Raynaud’s phenomenon. Arthritis Rheum 48:1992–2000CrossRefPubMed Rajagopalan S, Pfenninger D, Kehrer C et al (2003) Increased asymmmetric dimethylarginine and endothelin1 levels in secondary Raynaud’s phenomenon. Arthritis Rheum 48:1992–2000CrossRefPubMed
8.
Zurück zum Zitat Gazi I, Jagroop IA, Mikhailidis DP (2006) Endothelin-1, platelets and Raynaud’s phenomenon. Int Angiol 25:436PubMed Gazi I, Jagroop IA, Mikhailidis DP (2006) Endothelin-1, platelets and Raynaud’s phenomenon. Int Angiol 25:436PubMed
9.
Zurück zum Zitat Brevetti G, De Caterina M, Martone VD et al (2000) Measurement of soluble adhesion molecules in primary Raynaud’s phenomenon secondary to connective tissue diseases. Int J Clin Lab Res 30:75–81CrossRefPubMed Brevetti G, De Caterina M, Martone VD et al (2000) Measurement of soluble adhesion molecules in primary Raynaud’s phenomenon secondary to connective tissue diseases. Int J Clin Lab Res 30:75–81CrossRefPubMed
10.
Zurück zum Zitat Denton CP, Bickerstaff MC, Shiwen X et al (1995) Serial circulating adhesion molecule levels reflect disease severity in Systemic Sclerosis. Br J Rheumatol 34:1048–1054CrossRefPubMed Denton CP, Bickerstaff MC, Shiwen X et al (1995) Serial circulating adhesion molecule levels reflect disease severity in Systemic Sclerosis. Br J Rheumatol 34:1048–1054CrossRefPubMed
11.
Zurück zum Zitat Sedimbi SK, Hägglӧf T, Karlsson MCI (2013) IL-18 in inflammatory and autoimmune disease. Cell Mol Life Sci 70:4795–808CrossRefPubMed Sedimbi SK, Hägglӧf T, Karlsson MCI (2013) IL-18 in inflammatory and autoimmune disease. Cell Mol Life Sci 70:4795–808CrossRefPubMed
12.
14.
Zurück zum Zitat Cals-Grierson M-M, Ormerod AD (2004) Nitric Oxide function in the skin. Nitric Oxide 10:179–193CrossRefPubMed Cals-Grierson M-M, Ormerod AD (2004) Nitric Oxide function in the skin. Nitric Oxide 10:179–193CrossRefPubMed
15.
Zurück zum Zitat Dooley A, Gao B, Bradley N et al (2006) Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology 45:676–684CrossRefPubMed Dooley A, Gao B, Bradley N et al (2006) Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. Rheumatology 45:676–684CrossRefPubMed
16.
Zurück zum Zitat Tucker AT, Pearson RM, Cooke ED, Benjamin N (1999) Effect of nitric-oxide-generating system on microcirculatory blood flow in skin of patients with severe Raynaud’s syndrome: a randomized trial. Lancet 354:1670–1675CrossRefPubMed Tucker AT, Pearson RM, Cooke ED, Benjamin N (1999) Effect of nitric-oxide-generating system on microcirculatory blood flow in skin of patients with severe Raynaud’s syndrome: a randomized trial. Lancet 354:1670–1675CrossRefPubMed
17.
Zurück zum Zitat LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed LeRoy EC, Medsger TA Jr (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488PubMed
18.
Zurück zum Zitat Pavlov-Dolijanović S, Damjanov N, Ostojić P et al (2006) The prognostic value of nailfold capiillary changes for the development connective tissue disease in children and adolescents with primary Raynaud phenomenon: a follow-up study of 250 patients. Pediatr Dermatol 23:437–442CrossRefPubMed Pavlov-Dolijanović S, Damjanov N, Ostojić P et al (2006) The prognostic value of nailfold capiillary changes for the development connective tissue disease in children and adolescents with primary Raynaud phenomenon: a follow-up study of 250 patients. Pediatr Dermatol 23:437–442CrossRefPubMed
20.
Zurück zum Zitat Bollinger A, Fagrell B (1990) Clinical capillaroscopy. Hogrefe + Huber Publishers, Toronto-S tuttgart, pp 77–92 Bollinger A, Fagrell B (1990) Clinical capillaroscopy. Hogrefe + Huber Publishers, Toronto-S tuttgart, pp 77–92
21.
Zurück zum Zitat Cutolo M, Sulli A, Smith V (2011) Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover? Expert Rev Clin Immunol 7:395–397CrossRefPubMed Cutolo M, Sulli A, Smith V (2011) Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover? Expert Rev Clin Immunol 7:395–397CrossRefPubMed
22.
Zurück zum Zitat Lambova SN, Mϋller-Ladner U (2009) The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29:1263–1271CrossRefPubMed Lambova SN, Mϋller-Ladner U (2009) The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29:1263–1271CrossRefPubMed
23.
Zurück zum Zitat Lambova SN, Mϋller-Ladner U (2013) Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: what we still have to learn? Rheumatol Int 33:689–695CrossRefPubMed Lambova SN, Mϋller-Ladner U (2013) Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: what we still have to learn? Rheumatol Int 33:689–695CrossRefPubMed
24.
Zurück zum Zitat Kim HS, Park MK, Kim HY, Park SH (2010) Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis. Clin Rheumatol 29:247–254CrossRefPubMed Kim HS, Park MK, Kim HY, Park SH (2010) Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis. Clin Rheumatol 29:247–254CrossRefPubMed
25.
Zurück zum Zitat Kuryliszyn–Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S (2009) Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity. Scand J Rheumatol 38:38–45CrossRefPubMed Kuryliszyn–Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S (2009) Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity. Scand J Rheumatol 38:38–45CrossRefPubMed
26.
Zurück zum Zitat Kuryliszyn-Moskal A, Dubicki A, Zarzycki W et al (2011) Microvascular abnormalities in capillaroscopy correlate with higher serum IL-18 and E-selectin levels in patients with type 1 diabetes complicated by microangiopathy. Folia Histochem Cytobiol 49:104–110CrossRefPubMed Kuryliszyn-Moskal A, Dubicki A, Zarzycki W et al (2011) Microvascular abnormalities in capillaroscopy correlate with higher serum IL-18 and E-selectin levels in patients with type 1 diabetes complicated by microangiopathy. Folia Histochem Cytobiol 49:104–110CrossRefPubMed
27.
Zurück zum Zitat Yamane K (1994) Endothelin and collagen vascular disease: a review with special reference to Raynaud’s phenomenon and systemic sclerosis. Intern Med 33:579–582CrossRefPubMed Yamane K (1994) Endothelin and collagen vascular disease: a review with special reference to Raynaud’s phenomenon and systemic sclerosis. Intern Med 33:579–582CrossRefPubMed
28.
Zurück zum Zitat Edwards CM, Marshall JM, Pugh M (1999) Cardiovascular responses evoked by mild cool stimuli in primary Raynaud’s disease: the role of endothelin. Clin Sci 96:577–588PubMed Edwards CM, Marshall JM, Pugh M (1999) Cardiovascular responses evoked by mild cool stimuli in primary Raynaud’s disease: the role of endothelin. Clin Sci 96:577–588PubMed
29.
Zurück zum Zitat Dӧrffler-Melly J, Lϋschier TF, Wenk M et al (1996) Endothelin-1 and cold provocation in health, primary Raynaud’s phenomenon, and progressive systemic sclerosis. Microvasc Res 52:193–197CrossRef Dӧrffler-Melly J, Lϋschier TF, Wenk M et al (1996) Endothelin-1 and cold provocation in health, primary Raynaud’s phenomenon, and progressive systemic sclerosis. Microvasc Res 52:193–197CrossRef
30.
Zurück zum Zitat Blann A, Illingworth K, Jayson M (1993) Mechanism of endothelial cell damage in systemic sclerosis and Raynaud’s phenomenon. J Rheumatol 20:1325–1330PubMed Blann A, Illingworth K, Jayson M (1993) Mechanism of endothelial cell damage in systemic sclerosis and Raynaud’s phenomenon. J Rheumatol 20:1325–1330PubMed
31.
Zurück zum Zitat Gruschwitz M, Hornstein O, Driesch P (1995) Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity? Arthritis Rheum 38:184–189CrossRefPubMed Gruschwitz M, Hornstein O, Driesch P (1995) Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity? Arthritis Rheum 38:184–189CrossRefPubMed
32.
Zurück zum Zitat Amin MA, Mansfield PJ, Pakozdi A (2007) IL-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum 56:1787–1797CrossRefPubMed Amin MA, Mansfield PJ, Pakozdi A (2007) IL-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum 56:1787–1797CrossRefPubMed
33.
Zurück zum Zitat Favilli F, Anzilotte C, Martinelli L (2009) IL-18 activity in systemic lupus erythematosus. Contemporary challenges in autoimmunity. Ann NY Acad Sci 1173:301–309CrossRefPubMed Favilli F, Anzilotte C, Martinelli L (2009) IL-18 activity in systemic lupus erythematosus. Contemporary challenges in autoimmunity. Ann NY Acad Sci 1173:301–309CrossRefPubMed
34.
Zurück zum Zitat Romero LI, Zhang DN, Cooke JP et al (2000) Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma. Vasc Med 5:147–158CrossRefPubMed Romero LI, Zhang DN, Cooke JP et al (2000) Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma. Vasc Med 5:147–158CrossRefPubMed
35.
Zurück zum Zitat Yamamoto T, Katayama I, Nishioka K (1998) Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 25:314–317PubMed Yamamoto T, Katayama I, Nishioka K (1998) Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol 25:314–317PubMed
36.
Zurück zum Zitat Yamamoto T, Sawada Y, Katayama I, Nishioka K (1998) Increased production of nitric oxide stimulated by interleukine-1β in peripheral blood mononuclear cells in patients with systemic sclerosis. Br J Rheumatol 37:1123–1125CrossRefPubMed Yamamoto T, Sawada Y, Katayama I, Nishioka K (1998) Increased production of nitric oxide stimulated by interleukine-1β in peripheral blood mononuclear cells in patients with systemic sclerosis. Br J Rheumatol 37:1123–1125CrossRefPubMed
37.
Zurück zum Zitat Neumann Andersen G, Caidahl K, Kazzam E et al (2000) Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis. Arthritis Rheum 43:1085–1093CrossRef Neumann Andersen G, Caidahl K, Kazzam E et al (2000) Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis. Arthritis Rheum 43:1085–1093CrossRef
38.
Zurück zum Zitat Choi JW (2003) Nitric oxide productions increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity. Clin Chim Acta 336:83–87CrossRefPubMed Choi JW (2003) Nitric oxide productions increased in patients with rheumatoid arthritis but does not correlate with laboratory parameters of disease activity. Clin Chim Acta 336:83–87CrossRefPubMed
39.
Zurück zum Zitat Bica BE, Gomes NM, Fernandes PD et al (2007) Nitric oxide levels and the severity of juvenile idiopathic arthritis. Rheumatol Int 27:819–825CrossRefPubMed Bica BE, Gomes NM, Fernandes PD et al (2007) Nitric oxide levels and the severity of juvenile idiopathic arthritis. Rheumatol Int 27:819–825CrossRefPubMed
40.
Zurück zum Zitat Belmont HM, Levartovsky D, Goel A et al (1997) Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 40:1810–1816CrossRefPubMed Belmont HM, Levartovsky D, Goel A et al (1997) Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 40:1810–1816CrossRefPubMed
41.
Zurück zum Zitat Kahaleh BM, Fan P (1998) Down regulation of nitric oxide synthase gene in microvascular endothelial cells from lesional scleroderma: assessment by quantitative RT-PCR and possible role for cytotoxic T cells. Arthritis Rheum 41(Suppl):1469 Kahaleh BM, Fan P (1998) Down regulation of nitric oxide synthase gene in microvascular endothelial cells from lesional scleroderma: assessment by quantitative RT-PCR and possible role for cytotoxic T cells. Arthritis Rheum 41(Suppl):1469
42.
Zurück zum Zitat Allanore Y, Borderie D, Hilliquin P et al (2001) Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells. Rheumatology 40:1089–1996CrossRefPubMed Allanore Y, Borderie D, Hilliquin P et al (2001) Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells. Rheumatology 40:1089–1996CrossRefPubMed
43.
Zurück zum Zitat Kundu D, Abraham D, Black CM et al (2014) Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud’s Phenomenon. Vasc Pharmacol 63:178–181CrossRef Kundu D, Abraham D, Black CM et al (2014) Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud’s Phenomenon. Vasc Pharmacol 63:178–181CrossRef
44.
Zurück zum Zitat Matucci-Cerinic M, Kahaleh MB (2002) Beauty and the Beast. The nitric oxide paradox in systemic sclerosis. Rheumatology 41:843–847CrossRefPubMed Matucci-Cerinic M, Kahaleh MB (2002) Beauty and the Beast. The nitric oxide paradox in systemic sclerosis. Rheumatology 41:843–847CrossRefPubMed
45.
Zurück zum Zitat Ringqvist I, Hedner T, Leppert J et al (1993) Effects of cold pressor test on circulating atrial natriuretic peptide 99–126 (ANP) in patients with Raynaud’s phenomenon and influence of treatment with magnesium sulphate and nifedipine. Clin Physiol 13:271–280CrossRefPubMed Ringqvist I, Hedner T, Leppert J et al (1993) Effects of cold pressor test on circulating atrial natriuretic peptide 99–126 (ANP) in patients with Raynaud’s phenomenon and influence of treatment with magnesium sulphate and nifedipine. Clin Physiol 13:271–280CrossRefPubMed
46.
Zurück zum Zitat Herrick AL, Murray AK, Ruck A et al (2014) A double-blind, randomized, placebo-controlled crossover trial of the α2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis. Rheumatology (Oxford) 53:948–952CrossRef Herrick AL, Murray AK, Ruck A et al (2014) A double-blind, randomized, placebo-controlled crossover trial of the α2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis. Rheumatology (Oxford) 53:948–952CrossRef
47.
Zurück zum Zitat Fava A, Wung PK, Wigley FM et al (2012) Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud’s phenomenon. Arthritis Care Res (Hoboken) 64:925–929CrossRef Fava A, Wung PK, Wigley FM et al (2012) Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud’s phenomenon. Arthritis Care Res (Hoboken) 64:925–929CrossRef
Metadaten
Titel
Nailfold capillaroscopy assessment of microcirculation abnormalities and endothelial dysfunction in children with primary or secondary Raynaud syndrome
verfasst von
Joanna Latuskiewicz-Potemska
Antonina Chmura-Skirlinska
Ryszard J. Gurbiel
Elzbieta Smolewska
Publikationsdatum
29.06.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 8/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3340-8

Weitere Artikel der Ausgabe 8/2016

Clinical Rheumatology 8/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.